Dow Down 0.25% Nasdaq Down 0.14%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
10.49 Down 0.17(1.59%) Sep 29, 4:00PM EDT
|After Hours : 10.49 Down 0.00 (0.01%) Sep 29, 4:53PM EDT
Prev Close:10.66
Open:10.47
Bid:10.26 x 100
Ask:11.24 x 2000
1y Target Est:17.73
Beta:3.29
Next Earnings Date: 6-Nov-14BCRX Earnings announcement
Day's Range:10.34 - 10.69
52wk Range:4.55 - 14.62
Volume:407,359
Avg Vol (3m):1,061,460
Market Cap:752.72M
P/E (ttm):N/A
EPS (ttm):-0.64
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.59%752.72M
GSKDown 0.64%111.19B
RHHBYDown 0.24%250.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):42.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.83
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-1.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule pharmaceuticals that block key enzymes involved in the pathogenesis of diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback